Most U.S. hedge funds aren't expecting another big stock market sell-off as more firms curb bets on volatility, according to Nomura.Marketsread more
More tit-for-tat tariffs in the U.S.-China trade war could set the global economy up for a recession, according to Morgan Stanley.Marketsread more
A sell-off in chip stocks intensified following a report that chipmakers are cutting ties with Huawei after the Trump administration's ban.Marketsread more
A series of tweets Monday marked the latest chapter in Trump's decadeslong effort to refute published reports that his previous financial problems have rendered him an...Politicsread more
President Trump stands a chance of creating a new economic world order in his China trade fight, says the chief economic advisor of Allianz.Economyread more
Sens. Mitch McConnell and Tim Kaine plan to introduce a bill Monday that would raise the minimum age to buy tobacco to 21 in hopes of curbing what regulators are calling an...Health and Scienceread more
Ford Motor said Monday that it is laying off about 7,000 salaried workers, about 10% of that global workforce, as part of a restructuring plan designed to save the No. 2...Autosread more
Silicon Valley argues that the public market investors focus too much on near-term profits — but investors have embraced money-losing biotech IPOs.Marketsread more
Restaurants are thinking outside the box to attract and retain talent. A report from TDn2K, a restaurant analytics firm, finds that employee vacancies are a major concern for...Restaurantsread more
Forty percent of customers will choose a center to shop at based solely on the food that's there, JLL found in a new study. And nearly 38% of people want healthy options when...Retailread more
Harley was thrown into the spotlight of Trump's trade war last June after the company announced it would move production for its European products out of the U.S. because of...Autosread more
What Merlo does worry about is how CVS can meet the needs of its customers, he said Monday in an interview with David Rubenstein, president of the Economic Club of Washington, D.C. The company spends a lot of time listening to its customers to understand what they're not happy about and filling their unmet needs, he said.
"So that's what we focus on as an organization, with the goal being: Don't leave any white space for Amazon to disrupt," Merlo said.
Amazon bought its way into the prescription drug delivery business with a $1 billion acquisition of online pharmacy company PillPack. The move spooked Wall Street and shaved about $12.8 billion in market value from drugstores CVS, Walgreens Boots Alliance and Rite Aid.
PillPack sorts a person's medicines into clear pouches with labels explaining what's inside and when the person should take them. Merlo said it's a "very niche product" since it's designed for people with chronic conditions who take multiple drugs every day.
CVS said it offers a similar multi-dose-packaging product that incorporates a proprietary dosing schedule technology.
"We have that capability today," Merlo said. "And listen, with the acquisition of PillPack, there's nothing proprietary about their technology. It's off the shelf."
CVS is trying to become a disruptive force itself with its roughly $69 billion acquisition of health insurer Aetna. With the deal, CVS wants to manage chronic conditions such as diabetes at its MinuteClinics. They also want to steer people into these walk-in clinics and away from more expensive sites such as emergency rooms.
The Department of Justice last week gave the deal preliminary approval. CVS still needs states' approval. Merlo said Monday they're in the "home stretch" of that process.